首页> 外国专利> Chemical entity derived from pirazolopirimidina, inhibiting the ubiquitin Activating Enzyme 1 Crystalline anhydrous form; Form; 2 Crystalline Monohydrate; Pharmaceutical Composition and Method for treating cancer; and use for the treatment of Lung Cancer, ovarian cancer, colon cancer Breast Cancer, or Lymphoma.

Chemical entity derived from pirazolopirimidina, inhibiting the ubiquitin Activating Enzyme 1 Crystalline anhydrous form; Form; 2 Crystalline Monohydrate; Pharmaceutical Composition and Method for treating cancer; and use for the treatment of Lung Cancer, ovarian cancer, colon cancer Breast Cancer, or Lymphoma.

机译:来源于吡唑啉吡喃的化学实体,抑制泛素活化酶1结晶的无水形式;形成; 2结晶一水合物;药物组合物和治疗癌症的方法;并用于治疗肺癌,卵巢癌,结肠癌,乳腺癌或淋巴瘤。

摘要

Disclosed are chemical entities that inhibit ubiquitin-activating enzyme (UAE), each of which is a compound of Formulaor a pharmaceutically acceptable salt thereof, wherein Y isand W, Z, X, R, Rand Rare defined herein; pharmaceutical compositions comprising the chemical entities; and methods of using the chemical entities. These chemical entities are useful for treating disorders, particularly cell proliferation disorders, including cancers.
机译:公开了抑制泛素活化酶(UAE)的化学实体,其各自为下式的化合物或其药学上可接受的盐,其中Y为本文定义的W,Z,X,R,R 1和R 2。包含化学实体的药物组合物;以及使用化学实体的方法。这些化学实体可用于治疗疾病,特别是细胞增殖疾病,包括癌症。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号